Standard Biotools (LAB) Other Non-Current Assets (2010 - 2025)

Standard Biotools (LAB) has 16 years of Other Non-Current Assets data on file, last reported at $228.4 million in Q4 2025.

• Other Non-Current Assets for Q4 2025 came in at $228.4 million, up 24.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $228.4 million (up 24.52% YoY), and the FY2025 annual result was $228.4 million, up 24.52% from the prior year.
• Other Non-Current Assets advanced to $228.4 million in Q4 2025 per LAB's latest filing, from $6.5 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $228.4 million in Q4 2025 and troughed at $1.0 million in Q2 2021.
• A 5-year average of $26.0 million and a median of $3.6 million in 2022 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2021 and 2024: Other Non-Current Assets tumbled 79.82% in 2021, then jumped 7927.66% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $3.7 million in 2021, then decreased by 15.72% to $3.1 million in 2022, then retreated by 26.5% to $2.3 million in 2023, then jumped by 7927.66% to $183.4 million in 2024, then rose by 24.52% to $228.4 million in 2025.
• Business Quant data shows LAB's Other Non-Current Assets at $228.4 million in Q4 2025, $6.5 million in Q1 2025, and $183.4 million in Q4 2024.